Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCOG ALL-11 trial for newly diagnosed childhood acute lymphoblastic leukemia
NL-OMON47149Phase 3Active, not recruiting
- Sponsor
- SKion
- Start
- Nov 2012
- Modality
- Recombinant Proteins and Enzymes, Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of pegaspargase, immune globulin in acute lymphoblastic leukemia (ALL), sponsored by SKion. Started Nov 2012; status: active, not recruiting.
02
Drugs
pegaspargaseimmune globulin
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NL-OMON47149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47149.